Evaluating Senior Protection: Shortfalls in Portugal Relative to Canada

 As Western societies grapple with the challenges of an ageing population, the contrast between Canada and Portugal in their fiscal treatment of retired citizens highlights two markedly different policy approaches. In Canada, mechanisms such as subsection 217 of the Income Tax Act provide seniors with limited income a degree of protection from additional tax burdens, particularly when they rely solely on pension income. The provision, widely used by residents and non‑residents alike, acts as an economic safeguard that acknowledges the financial vulnerability associated with old age.

Portugal presents a different picture. Despite repeated political commitments to prioritise the well‑being of older citizens, the Portuguese tax system remains rigid, offering little differentiation between taxpayers with substantial financial resources and those whose pensions barely cover essential living costs. The taxation of foreign pensions — even when the source country chooses not to tax them — illustrates this inflexibility. Unlike Canada, Portugal offers no comparable mechanism that would allow seniors facing economic hardship to obtain relief from tax obligations.

Social policy experts have long warned about the absence of targeted protections for this demographic. The lack of a “hardship‑based relief” system similar to Canada’s leaves many elderly residents exposed to a tax burden that does not reflect their financial reality. In a country where the cost of living has risen steadily, the absence of tailored measures raises questions about the effectiveness of public policies aimed at supporting older citizens.

While Canada continues to strengthen its protective mechanisms, Portugal struggles to translate political intentions into concrete action. The comparison between the two countries underscores not only divergent fiscal strategies but also differing priorities in how each nation treats its most vulnerable citizens.

Science Said “Ban It,” the Trump EPA Said “Never Mind

Sometimes a single regulatory decision captures an entire administration’s philosophy. The chlorpyrifos episode is one of those moments. Chlorpyrifos is an organophosphate pesticide—chemically related to the same class of compounds that once formed the basis of nerve agents. For years, scientists at the Environmental Protection Agency reviewed the evidence and concluded that the chemical posed unacceptable risks to children’s neurological development. Their recommendation was clear: ban it. The ban was already in motion. The scientific review was complete. The legal standard had been met. All that remained was finalization. Then the Trump administration arrived. Within weeks, the EPA leadership overrode its own scientists and halted the ban. The decision didn’t come with new evidence, new analysis, or new data—just a new political calculus. The pesticide would remain on apples, citrus, strawberries, and other foods children eat every day. The timing raised eyebrows for a reason. Dow Chemical, the manufacturer of chlorpyrifos, had donated $1 million to Trump’s inauguration. The company had also lobbied aggressively against the ban. There is no proven quid pro quo, but the optics are impossible to ignore: scientists recommended protecting chil

dren’s health, and the administration sided with the donor. This is not a story about partisan preference. It is a story about what happens when scientific judgment is treated as optional—when evidence becomes negotiable, and when regulatory decisions appear to hinge less on public health than on political convenience. The chlorpyrifos reversal was audacious not because it was surprising, but because it was so blunt. It told the country, in effect, that expert analysis could be discarded with a signature, and that the appearance of influence was a secondary concern. Public health deserves better than that.

dominiquemellow.com